The AstraZeneca PLC ADR AZN shed 1.22% to $72.60 Tuesday, on what proved to be an all-around mixed trading session for the ...
In a report released today, Matthew Weston from UBS maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...
J.P. Morgan analyst James Gordon maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £140.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback